Ellington Residential Stock (NYSE:EARN), Trade Ideas

Ellington Residential

Ellington Residential Mortgage REIT is principally engaged in the business of acquiring, investing in, and managing residential mortgage- and real estate-related assets through its wholly-owned subsidiaries. The company's primary objective is to generate attractive current yields and risk-adjusted total returns for its shareholders by investing in assets that compensate appropriately for the risks associated with them.

Wooden,Blocks,With,Percentage,Sign,And,Arrow,Up,,Financial,Growth,

Real Estate

EARN

Mortgage REITs Are Making A Comeback

Earnings

News

SAFE

Safehold (NYSE: SAFE) came out with quarterly earnings of $0.37 per share, missing the Zacks Consensus Estimate of $0.40 per share. This compares to earnings of $0.28 per share a year ago. These figures are adjusted for non-recurring items.

Safehold (SAFE) Misses Q2 Earnings And Revenue Estimates

Penny Stocks

REIT

Small Cap

AGNC

NYMT

It’s entirely possible to receive much higher dividend yields on certain real estate investment trusts (REITs) than on the 10-year Treasury Note rate right now if you’re willing to accept more risk. In alphabetical order, these six real estate investment trusts pay big dividends:

Lock In High Dividend Yields While Prices Are Still Down On These 7 REITs

Ellington Residential Mortgage REIT Common Shares of Beneficial Interest

Ellington Residential Mortgage REIT

Earntz Healthcare Products, Inc

JMP Securities analyst Mikhail Goberman reiterates Ellington Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) with a Market Perform.

Reiteration

Analyst Ratings

JMP Securities Reiterates Market Perform on Ellington Residential

After a long bear market, mortgage real estate investment trusts (mREITs) are apparently making a comeback. Eight of the 12 best-performing REITs over the last five trading days have been mREITs. Four of the mREITs have also produced double-digit gains over the last month.
Several of these mREITs are low-priced and have been volatile over long time frames. But mREITs are extremely interest rate sensitive, and with the 10-year U.S. Treasury bonds peaking in October and having declined by three-quarters of a percent since then, mREITs have been able to find firm footing again.&nbsp;
Take a look at three mREITs with the best total returns over the last five- and 30-day periods.&nbsp;
Lument Finance Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LFT#NYSE">LFT</a>) is a New York City-based mREIT focused on commercial real estate debt investments, with 94% in the multifamily sector and the rest divided between senior housing and healthcare and self-storage facilities. Of its $1.4 billion loan portfolio, 28% is in Texas and 16.3% is in Florida. At the end of 2023, 96.7% of its loans were performing, just slightly below the 97.9% rate at the end of 2022. Lument Finance Trust is externally managed by Lument Investment Management LLC, an affiliate of ORIX Corp. USA.
<h2 class="wp-block-heading">Don't Miss:</h2>
<ul>
<li>Investing in real estate just got a whole lot simpler. This <a href="https://www.benzinga.com/go/bezos-landlord">Jeff Bezos-backed startup will allow you to become a landlord</a> in just 10 minutes, and you only need $100.</li>
<li>Want To Grow Your Wealth Passively? <a href="https://www.benzinga.com/go/grow-wealth-passively">These High-Yield Real Estate Notes Might Be Your Holy Grail</a></li>
</ul>
It would have taken a great deal of courage to buy shares of Lument Finance Trust in early May 2023 when it was trading at $1.46, but investors who did and have held the shares since then have a 73% gain to its recent closing price of $2.53.
Over the past month, Lument Finance Trust is up 10% and from March 18 to March 25, its total return has been 15%.
Lument Finance pays a quarterly dividend of $0.07 per share and the annual dividend of $0.28 per share presently yields 11.06%. The dividend was cut from $0.09 to $0.06 per share in March 2022 but was increased to $0.07 per share in September 2023. The payout ratio of 68.2% is moderate and fourth-quarter earnings and revenue were both solid improvements from the year-ago quarter, which reduces the possibility of another dividend cut anytime soon.
Acres Commercial Realty Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACR#NYSE">ACR</a>) is a Uniondale, New York-based mREIT that specializes in originating, holding and managing mortgage loans and other debt instruments for commercial real estate (CRE). Its main focus is on lending to multifamily properties. Acres Commercial is externally managed by ACRES Capital LLC, a subsidiary of ACRES Capital Corp.
Acres Commercial has a total of $2.2 billion in assets. Its most recent percentage of current loan portfolio payments is 98%.&nbsp;
<h2 class="wp-block-heading">Trending</h2>
<ul>
<li>Miami Is Expected To Take New York's Place As The US Financial Capital. <a href="https://www.benzinga.com/go/miami-financial-capital">Invest In It With $500 Before That Happens</a>.</li>
</ul>
On Nov. 30, Acres Commercial announced that its board has reauthorized an additional $10 million share repurchase program as well as continuing its preexisting program of $4.1 million of common stock.
On Feb. 28, Acres Commercial reported fourth-quarter earnings per share (EPS) of $0.55 per share, beating the estimate of $0.47. Revenue of $22.45 million was also ahead of the estimate of $19.6 million, although it was slightly below fourth-quarter 2022 revenue of $23.24 million.
Acres Commercial has been an incredible performer since the end of November, rising approximately 70% over that time. From March 18 to March 25, Acres Commercial Realty produced a total gain of 10.82%. Over the past month, its total gain is 21.1%.
One thing to keep in mind is that Acres Commercial only pays dividends on its preferred stock. The common stock dividend was suspended after 2019 and has not been reinstated.
Ellington Residential Mortgage REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) is an Old Greenwich, Connecticut-based mREIT that acquires, invests in and manages residential mortgages and other real estate assets. Ellington uses residential mortgage-backed securities for which the principal and interest payments are backed by a U.S. government agency or government-sponsored entity. Ellington Residential is externally managed by investment adviser and affiliate Ellington Management Group LLC. Ellington Residential has $10.3 billion in assets under management.
On March 7, Ellington announced its next monthly dividend payment of $0.08 per share, which is payable on April 25 to shareholders as of March 29. The $0.96 per share annualized dividend presently yields 13.73%. The payout ratio is high at 86.4%, but the dividend is still covered and EPS has been steadily increasing over the past year.&nbsp;
From March 18 through March 25, Ellington Residential had a total gain of 7.04%. Over the past month, its total gain is 17.05%.
Investor note: mREITs can be volatile and are not well-suited for more conservative investors. However, with the prospect of the Federal Reserve rate cuts coming, top-notch recent appreciation on all three and high dividend yields on two of them, these mREITs could be excellent, albeit more speculative purchases.
Read Next:
<ul>
<li>Collecting passive income from real estate just got a whole lot simpler. A new <a href="https://www.benzinga.com/go/dara-backed-startup?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=site">real estate fund backed by Dara Khosrowshahi</a> gives you instant access to a diversified portfolio of rental properties, and you only need $100 to get started.</li>
<li>Elon Musk Is Bullish On Austin. Here&#8217;s <a href="https://www.benzinga.com/go/musk-austin">How To Invest In The City&#8217;s Growth Before He Floods It With New Tech Workers</a>.</li>
</ul>

Ellington Residential Mortgage REIT's Board Of Trustees Has Approved Investment Strategy To Focus On Corporate Collateralized Loan Obligations. It Will Build Upon Its $44M CLO Portfolio, With An Emphasis On Secondary CLO Mezzanine Debt, Equity Tranches

Ellington Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.23 by 17.39 percent. This is a 8 percent increase over earnings of $0.25 per share from the same period last year.

Ellington Residential Q4 Adj. EPS $0.27 Beats $0.23 Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; CTS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTS#NYSE">CTS</a>) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
&bull; Foot Locker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) is likely to report quarterly earnings at $0.32 per share on revenue of $2.28 billion.
&bull; JD.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) is likely to report quarterly earnings at $0.63 per share on revenue of $42.16 billion.
&bull; Super Group (SGHC) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGHC#NYSE">SGHC</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $326.63 million.
&bull; Sotherly Hotels (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOHO#NASDAQ">SOHO</a>) is projected to report earnings for its fourth quarter.
&bull; Thor Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THO#NYSE">THO</a>) is estimated to report quarterly earnings at $0.67 per share on revenue of $2.27 billion.
&bull; Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) is expected to report quarterly earnings at $0.10 per share on revenue of $86.80 million.
&bull; VersaBank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VBNK#NASDAQ">VBNK</a>) is likely to report quarterly earnings at $0.35 per share on revenue of $22.43 million.
&bull; Abercrombie &amp; Fitch (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) is expected to report quarterly earnings at $2.83 per share on revenue of $1.43 billion.
&bull; Brown Forman Inc Class B Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) is expected to report quarterly earnings at $0.56 per share on revenue of $1.12 billion.
&bull; WAVE Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WVE#NASDAQ">WVE</a>) is likely to report quarterly loss at $0.23 per share on revenue of $19.86 million.
&bull; Yatsen Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YSG#NYSE">YSG</a>) is projected to report earnings for its fourth quarter.
&bull; iShares $ Short Duration Corp Bond UCITS ETF USD (Dist) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDIG#NASDAQ">SDIG</a>) is projected to report quarterly loss at $0.98 per share on revenue of $22.21 million.
&bull; InspireMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSPR#NASDAQ">NSPR</a>) is expected to report quarterly loss at $0.19 per share on revenue of $1.63 million.
&bull; Korn Ferry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFY#NYSE">KFY</a>) is estimated to report quarterly earnings at $0.99 per share on revenue of $658.50 million.
&bull; Kamada (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KMDA#NASDAQ">KMDA</a>) is projected to report quarterly earnings at $0.05 per share on revenue of $37.71 million.
&bull; PureCycle Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) is projected to report quarterly loss at $0.23 per share on revenue of $180 thousand.
&bull; Xeris Biopharma Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XERS#NASDAQ">XERS</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $43.55 million.
&bull; Genius Sports (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GENI#NYSE">GENI</a>) is expected to report quarterly loss at $0.07 per share on revenue of $126.13 million.
&bull; Adaptimmune Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAP#NASDAQ">ADAP</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $20.47 million.
&bull; NeueHealth (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEUE#NYSE">NEUE</a>) is estimated to report quarterly loss at $4.16 per share on revenue of $283.44 million.
&bull; Campbell Soup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NYSE">CPB</a>) is projected to report quarterly earnings at $0.77 per share on revenue of $2.44 billion.
&bull; EVgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGO#NASDAQ">EVGO</a>) is projected to report quarterly loss at $0.18 per share on revenue of $44.03 million.
&bull; Hippo Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIPO#NYSE">HIPO</a>) is estimated to report quarterly loss at $2.01 per share on revenue of $55.25 million.
&bull; BrainsWay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWAY#NASDAQ">BWAY</a>) is expected to report quarterly loss at $0.01 per share on revenue of $8.42 million.
&bull; Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) is estimated to report quarterly loss at $0.40 per share on revenue of $1.75 million.
&bull; European Wax Center (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWCZ#NASDAQ">EWCZ</a>) is projected to report quarterly earnings at $0.07 per share on revenue of $54.08 million.
&bull; REV Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REVG#NYSE">REVG</a>) is likely to report quarterly earnings at $0.15 per share on revenue of $579.42 million.
&bull; United Natural Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNFI#NYSE">UNFI</a>) is likely to report quarterly loss at $0.01 per share on revenue of $7.87 billion.
&bull; Berry Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRY#NASDAQ">BRY</a>) is projected to report quarterly earnings at $0.24 per share on revenue of $182.37 million.
&bull; Brown Forman Inc Class A Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) is estimated to report earnings for its third quarter.
&bull; Trinity Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIN#NASDAQ">TRIN</a>) is estimated to report quarterly earnings at $0.54 per share on revenue of $46.42 million.
&bull; Antero Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AR#NYSE">AR</a>) is expected to report earnings for its fourth quarter.
<h3>Companies Reporting After The Bell</h3>
&bull; Descartes Systems Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSGX#NASDAQ">DSGX</a>) is likely to report quarterly earnings at $0.37 per share on revenue of $144.29 million.
&bull; Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) is estimated to report quarterly loss at $0.19 per share on revenue of $293.53 million.
&bull; Fortuna Silver Mines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSM#NYSE">FSM</a>) is estimated to report quarterly earnings at $0.10 per share on revenue of $261.00 million.
&bull; Inovio Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) is estimated to report quarterly loss at $1.27 per share on revenue of $340 thousand.
&bull; Companhia Siderurgica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SID#NYSE">SID</a>) is likely to report quarterly earnings at $0.19 per share on revenue of $2.32 billion.
&bull; Global X Silver Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIL#NYSE">SIL</a>) is expected to report quarterly earnings at $0.10 per share on revenue of $44.09 million.
&bull; TDCX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDCX#NYSE">TDCX</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $121.92 million.
&bull; Vermilion Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VET#NYSE">VET</a>) is expected to report quarterly earnings at $0.52 per share on revenue of $440.69 million.
&bull; VSE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSEC#NASDAQ">VSEC</a>) is expected to report quarterly earnings at $0.75 per share on revenue of $234.91 million.
&bull; Victoria&#39;s Secret (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) is projected to report quarterly earnings at $2.47 per share on revenue of $2.09 billion.
&bull; SandRidge Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SD#NYSE">SD</a>) is likely to report earnings for its fourth quarter.
&bull; CPS Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPSH#NASDAQ">CPSH</a>) is projected to report earnings for its fourth quarter.
&bull; Grove Collaborative Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GROV#NYSE">GROV</a>) is expected to report quarterly loss at $0.23 per share on revenue of $61.45 million.
&bull; KLX Energy Services Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLXE#NASDAQ">KLXE</a>) is projected to report quarterly earnings at $0.01 per share on revenue of $212.97 million.
&bull; Culp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CULP#NYSE">CULP</a>) is likely to report quarterly loss at $0.16 per share on revenue of $59.49 million.
&bull; GEN Restaurant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENK#NASDAQ">GENK</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $43.95 million.
&bull; MISTRAS Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MG#NYSE">MG</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $174.28 million.
&bull; IDT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDT#NYSE">IDT</a>) is projected to report earnings for its second quarter.
&bull; FRP Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPH#NASDAQ">FRPH</a>) is projected to report earnings for its fourth quarter.
&bull; Global Water Resources (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWRS#NASDAQ">GWRS</a>) is estimated to report quarterly earnings at $0.05 per share on revenue of $12.00 million.
&bull; NeoGames (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGMS#NASDAQ">NGMS</a>) is projected to report quarterly loss at $0.07 per share on revenue of $54.53 million.
&bull; Hamilton Beach Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HBB#NYSE">HBB</a>) is estimated to report earnings for its fourth quarter.
&bull; Amplify Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPY#NYSE">AMPY</a>) is likely to report quarterly earnings at $0.18 per share on revenue of $76.22 million.
&bull; Pampa Energia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAM#NYSE">PAM</a>) is likely to report quarterly loss at $0.09 per share on revenue of $421.19 million.
&bull; Talphera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLPH#NASDAQ">TLPH</a>) is estimated to report quarterly loss at $0.20 per share on revenue of $280 thousand.
&bull; Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) is expected to report quarterly loss at $0.12 per share on revenue of $70 thousand.
&bull; HighPeak Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HPK#NASDAQ">HPK</a>) is expected to report quarterly earnings at $0.65 per share on revenue of $339.52 million.
&bull; BRC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRCC#NYSE">BRCC</a>) is estimated to report quarterly loss at $0.01 per share on revenue of $123.75 million.
&bull; MDxHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXH#NASDAQ">MDXH</a>) is likely to report quarterly loss at $0.11 per share on revenue of $18.14 million.
&bull; NACCO Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NC#NYSE">NC</a>) is estimated to report earnings for its fourth quarter.
&bull; Enhabit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHAB#NYSE">EHAB</a>) is expected to report quarterly earnings at $0.03 per share on revenue of $260.16 million.
&bull; Intrepid Potash (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) is projected to report quarterly loss at $0.06 per share on revenue of $43.57 million.
&bull; OneSpan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSPN#NASDAQ">OSPN</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $58.26 million.
&bull; Honest Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNST#NASDAQ">HNST</a>) is estimated to report quarterly loss at $0.08 per share on revenue of $84.14 million.
&bull; SilverCrest Metals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SILV#AMEX">SILV</a>) is expected to report quarterly earnings at $0.10 per share on revenue of $44.09 million.
&bull; AudioEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEYE#NASDAQ">AEYE</a>) is estimated to report quarterly loss at $0.11 per share on revenue of $7.93 million.
&bull; comScore (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCOR#NASDAQ">SCOR</a>) is likely to report quarterly earnings at $0.20 per share on revenue of $97.69 million.
&bull; Viemed Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMD#NASDAQ">VMD</a>) is projected to report quarterly earnings at $0.10 per share on revenue of $50.00 million.
&bull; Kewaunee Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KEQU#NASDAQ">KEQU</a>) is projected to report earnings for its third quarter.
&bull; ChromaDex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXC#NASDAQ">CDXC</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $20.98 million.
&bull; Whitestone REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSR#NYSE">WSR</a>) is projected to report earnings for its fourth quarter.
&bull; Aris Water Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARIS#NYSE">ARIS</a>) is estimated to report earnings for its fourth quarter.
&bull; OrthoPediatrics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KIDS#NASDAQ">KIDS</a>) is expected to report quarterly loss at $0.28 per share on revenue of $37.73 million.
&bull; Invesco National AMT-Free Municipal Bond ETFo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PZA#NYSE">PZA</a>) is estimated to report earnings for its fourth quarter.
&bull; Hudson Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HDSN#NASDAQ">HDSN</a>) is projected to report quarterly earnings at $0.08 per share on revenue of $40.28 million.
&bull; Stabilis Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNG#NASDAQ">SLNG</a>) is projected to report earnings for its fourth quarter.
&bull; Airgain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRG#NASDAQ">AIRG</a>) is projected to report quarterly loss at $0.20 per share on revenue of $10.00 million.
&bull; Finance of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOA#NYSE">FOA</a>) is projected to report quarterly loss at $0.08 per share on revenue of $63.22 million.
&bull; Yext (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YEXT#NYSE">YEXT</a>) is likely to report quarterly earnings at $0.07 per share on revenue of $100.24 million.
&bull; TriplePoint Venture Gwth (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPVG#NYSE">TPVG</a>) is expected to report quarterly earnings at $0.48 per share on revenue of $33.13 million.
&bull; CompoSecure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPO#NASDAQ">CMPO</a>) is estimated to report quarterly earnings at $0.23 per share on revenue of $96.49 million.
&bull; Kodiak Gas Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGS#NYSE">KGS</a>) is expected to report quarterly earnings at $0.29 per share on revenue of $222.52 million.
&bull; Cyber Hornet S&amp;P 500 and Bitcoin 75/25 Strategy ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZZZ#NASDAQ">ZZZ</a>) is likely to report quarterly earnings at $0.53 per share on revenue of $247.43 million.
&bull; Ellington Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) is projected to report quarterly earnings at $0.23 per share on revenue of $2.46 million.
&bull; Spire Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPIR#NYSE">SPIR</a>) is expected to report quarterly loss at $0.72 per share on revenue of $29.34 million.
&bull; Lulus Fashion Lounge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVLU#NASDAQ">LVLU</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $73.40 million.
&bull; Rush Street Interactive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSI#NYSE">RSI</a>) is likely to report quarterly loss at $0.03 per share on revenue of $178.56 million.
&bull; Hamilton Insurance Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HG#NYSE">HG</a>) is expected to report quarterly earnings at $0.65 per share on revenue of $15.30 million.
&bull; Infinera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFN#NASDAQ">INFN</a>) is likely to report quarterly earnings at $0.09 per share on revenue of $437.34 million.
&bull; Riley Exploration Permian (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/REPX#AMEX">REPX</a>) is estimated to report quarterly earnings at $1.60 per share on revenue of $94.75 million.
&bull; Zymeworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYME#NASDAQ">ZYME</a>) is expected to report quarterly loss at $0.43 per share on revenue of $15.45 million.
&bull; Miller Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLR#NYSE">MLR</a>) is projected to report earnings for its fourth quarter.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

ADAP

AEYE

AIRG

AMPY

ARIS

BRCC

BWAY

CDXC

CMPO

CPSH

CULP

DSGX

EHAB

EVGO

EWCZ

FRPH

GENI

GENK

GROV

GWRS

HDSN

HIPO

HNST

HTOO

INFN

KEQU

KIDS

KLXE

KMDA

LVLU

MDXH

NEUE

NEXN

NGMS

NSPR

OSPN

PowerShares Insured Municipal Bond Portfolio

REPX

REVG

SCOR

SDIG

SGHC

SILV

SLNG

SOHO

SPIR

TDCX

TLPH

TPVG

TRIN

UNFI

VBNK

VSCO

VSEC

XERS

YEXT

ZYME

Earnings Scheduled For March 6, 2024

Ellington Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) is set to give its latest quarterly earnings report on Wednesday, 2024-03-06. Here's what investors need to know before the announcement.
Analysts estimate that Ellington Residential will report an earnings per share (EPS) of $0.23. 
Ellington Residential bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company missed EPS by $0.03, which was followed by a 7.86% increase in the share price the next day.
Here's a look at Ellington Residential's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.24</td>
<td>0.22</td>
<td>0.24</td>
<td>0.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.21</td>
<td>0.17</td>
<td>0.21</td>
<td>0.25</td>
</tr>
<tr>
<td>Price Change %</td>
<td>8.0%</td>
<td>-2.0%</td>
<td>-2.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1709661691_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Ellington Residential were trading at $5.95 as of March 04. Over the last 52-week period, shares are down 20.7%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/EARN/earnings">To track all earnings releases for Ellington Residential visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Preview: Ellington Residential's Earnings

UBS analyst Douglas Harter initiates coverage on Ellington Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) with a Neutral rating and announces Price Target of $6.

Price Target

Initiation

UBS Initiates Coverage On Ellington Residential with Neutral Rating, Announces Price Target of $6

Ellington Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) reported quarterly earnings of $0.21 per share which missed the analyst consensus estimate of $0.24 by 12.5 percent. This is a 8.7 percent decrease over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $(1.10 million) which missed the analyst consensus estimate of $640.00 thousand by 271.25 percent. This is a 121.12 percent decrease over sales of $5.19 million the same period last year.

Earnings Misses

Ellington Residential Earlier Reported Q3 Adj $0.21 Misses $0.24 Estimate, Sales $(1.10M) Miss $640.00K Estimate

AACG

ABOS

ACIC

ACOR

ACTG

AFYA

AGRO

AKTS

AMPS

ASTR

ASUR

ATEX

ATXS

AZTA

BAER

BIOR

BIOX

BWEN

CARA

CELC

CLSD

CPLP

CYCC

DCTH

DFLI

DMAC

DRRX

DXYN

EDBL

ELUT

EYEN

FFIE

FTRE

GEVO

GLAD

GRCL

GRND

HOFV

HROW

HSAI

HSIC

ICAD

ICCC

ICMB

IMCC

JRSH

LICY

LUCD

LUNR

MBRX

MDAI

MITQ

MKFG

MNDY

MVLA

NABL

NVGS

NXGL

OCFT

OMQS

OPAL

OWLT

PLSE

PRSO

RBOT

RELI

ROIV

RVYL

SACH

SALM

SBLK

SKIN

SKYX

SLND

SMTI

SNDL

SOHU

SPRO

TBIO

THMO

TOVX

Earnings Scheduled For November 13, 2023

Ellington Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) reported its Q3 earnings results on Monday, November 13, 2023 at 08:00 AM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Ellington Residential missed estimated earnings by 12.5%, reporting an EPS of $0.21 versus an estimate of $0.24.
Revenue was down $6.29 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.05 which was followed by a 2.0% drop in the share price the next day.
Here's a look at Ellington Residential's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
<th>Q3 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.22</td>
<td>0.24</td>
<td>0.22</td>
<td>0.24</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.17</td>
<td>0.21</td>
<td>0.25</td>
<td>0.23</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>2.13M</td>
<td>3.17M</td>
<td>3.92M</td>
<td>4.49M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>-1M</td>
<td>-372K</td>
<td>2.45M</td>
<td>5.19M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Ellington Residential <a href="https://www.benzinga.com/quote/EARN/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Ellington Residential: Q3 Earnings Insights

Ellington Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) is set to give its latest quarterly earnings report on Monday, 2023-11-13. Here's what investors need to know before the announcement.
Analysts estimate that Ellington Residential will report an earnings per share (EPS) of $0.24. 
Ellington Residential bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.05, which was followed by a 2.0% drop in the share price the next day.
Here's a look at Ellington Residential's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
<th>Q3 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.22</td>
<td>0.24</td>
<td>0.22</td>
<td>0.24</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.17</td>
<td>0.21</td>
<td>0.25</td>
<td>0.23</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>-1.87%</td>
<td>2.92%</td>
<td>1.74%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2023/1699632134_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Ellington Residential were trading at $5.62 as of November 09. Over the last 52-week period, shares are down 19.57%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/EARN/earnings">To track all earnings releases for Ellington Residential visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview: Ellington Residential

Ellington Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) reported quarterly earnings of $0.17 per share which missed the analyst consensus estimate of $0.22 by 22.73 percent. This is a 39.29 percent decrease over earnings of $0.28 per share from the same period last year. The company reported quarterly sales of $(1.62 million) which missed the analyst consensus estimate of $2.13 million by 175.87 percent. This is a 122.71 percent decrease over sales of $7.12 million the same period last year.

Ellington Residential Q2 EPS $0.17 Misses $0.22 Estimate, Sales $(1.62M) Miss $2.13M Estimate

Ellington Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) reported its Q1 earnings results on Thursday, May 11, 2023 at 04:27 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Ellington Residential missed estimated earnings by 12.5%, reporting an EPS of $0.21 versus an estimate of $0.24.
Revenue was down $5.80 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.03 which was followed by a 2.92% increase in the share price the next day.
Here's a look at Ellington Residential's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2022</th>
<th>Q3 2022</th>
<th>Q2 2022</th>
<th>Q1 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.22</td>
<td>0.24</td>
<td>0.26</td>
<td>0.3</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.25</td>
<td>0.23</td>
<td>0.28</td>
<td>0.3</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>3.92M</td>
<td>4.49M</td>
<td>4.95M</td>
<td>5.60M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>2.45M</td>
<td>5.19M</td>
<td>7.12M</td>
<td>5.43M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Ellington Residential <a href="https://www.benzinga.com/quote/EARN/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Ellington Residential Q1 Earnings

Ellington Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) reported quarterly earnings of $0.21 per share which missed the analyst consensus estimate of $0.24 by 12.5 percent. This is a 30 percent decrease over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $(372.00 thousand) which missed the analyst consensus estimate of $3.17 million by 111.74 percent. This is a 106.85 percent decrease over sales of $5.43 million the same period last year.

Ellington Residential Q1 EPS $0.21 Misses $0.24 Estimate, Sales $(372.00K) Miss $3.17M Estimate

Ellington Residential Mortgage REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) (the &quot;Company&quot;) today announced its estimated book value per share of&nbsp;$8.56&nbsp;as of February 28, 2023, which reflects a year-to-date total economic return of approximately&nbsp;3.8%&nbsp;through February 28, 2023. This corrects the Company&#39;s commentary on its earnings call earlier today, where it estimated its book value per share, as opposed to its year-to-date total economic return, as having increased close to&nbsp;4%&nbsp;through February 28, 2023.

Reported Late Tuesday March 7, Ellington Residential Announces Estimated Book Value Of $8.56 Per Share As Of February 28, 2023

Ellington Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $0.22 by 13.64 percent. This is a 10.71 percent decrease over earnings of $0.28 per share from the same period last year.

Ellington Residential Q4 Adj. EPS $0.25 Beats $0.22 Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; Passage Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PASG#NASDAQ">PASG</a>) is estimated to report earnings for its fourth quarter.
&bull; Precigen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGEN#NASDAQ">PGEN</a>) is projected to report quarterly loss at $0.10 per share on revenue of $6.21 million.
&bull; Quanterix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QTRX#NASDAQ">QTRX</a>) is projected to report quarterly loss at $0.47 per share on revenue of $25.78 million.
&bull; Lordstown Motors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIDE#NASDAQ">RIDE</a>) is estimated to report quarterly loss at $0.27 per share on revenue of $1.29 million.
&bull; Adaptimmune Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAP#NASDAQ">ADAP</a>) is projected to report quarterly loss at $0.25 per share on revenue of $4.12 million.
&bull; Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) is likely to report earnings for its fourth quarter.
&bull; Quantum-Si (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) is projected to report earnings for its fourth quarter.
&bull; Science 37 Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNCE#NASDAQ">SNCE</a>) is expected to report quarterly loss at $0.18 per share on revenue of $14.21 million.
&bull; GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) is likely to report quarterly earnings at $0.05 per share on revenue of $35.42 million.
&bull; CECO Environmental (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) is estimated to report quarterly earnings at $0.16 per share on revenue of $105.10 million.
&bull; L.B. Foster (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSTR#NASDAQ">FSTR</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $127.35 million.
&bull; Azul (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZUL#NYSE">AZUL</a>) is projected to report quarterly loss at $0.44 per share on revenue of $931.75 million.
&bull; Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) is expected to report quarterly earnings at $0.58 per share on revenue of $1.04 billion.
<h3>Companies Reporting After The Bell</h3>
&bull; Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) is expected to report earnings for its fourth quarter.
&bull; Intrusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) is expected to report quarterly loss at $0.20 per share on revenue of $2.30 million.
&bull; Coherus BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRS#NASDAQ">CHRS</a>) is likely to report quarterly loss at $0.69 per share on revenue of $48.38 million.
&bull; NCS Multistage Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCSM#NASDAQ">NCSM</a>) is expected to report earnings for its fourth quarter.
&bull; Immuneering (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMRX#NASDAQ">IMRX</a>) is projected to report quarterly loss at $0.58 per share on revenue of $60 thousand.
&bull; Intrepid Potash (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) is estimated to report quarterly earnings at $0.94 per share on revenue of $50.30 million.
&bull; CTI BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTIC#NASDAQ">CTIC</a>) is likely to report earnings for its fourth quarter.
&bull; Trip.com Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>) is estimated to report earnings for its fourth quarter.
&bull; Crawford &amp; Company Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) is expected to report earnings for its fourth quarter.
&bull; Crawford &amp; Company Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) is projected to report quarterly earnings at $0.17 per share on revenue of $300.20 million.
&bull; Calavo Growers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVGW#NASDAQ">CVGW</a>) is projected to report quarterly earnings at $0.24 per share on revenue of $270.57 million.
&bull; RxSight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) is projected to report quarterly loss at $0.73 per share on revenue of $15.05 million.
&bull; Anika Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANIK#NASDAQ">ANIK</a>) is expected to report quarterly loss at $0.24 per share on revenue of $37.70 million.
&bull; HighPeak Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HPK#NASDAQ">HPK</a>) is projected to report quarterly earnings at $0.87 per share on revenue of $253.49 million.
&bull; AerSale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASLE#NASDAQ">ASLE</a>) is expected to report quarterly earnings at $0.20 per share on revenue of $122.66 million.
&bull; Nutanix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) is projected to report quarterly earnings at $0.11 per share on revenue of $464.96 million.
&bull; ThredUp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDUP#NASDAQ">TDUP</a>) is likely to report quarterly loss at $0.20 per share on revenue of $62.92 million.
&bull; Akoya Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKYA#NASDAQ">AKYA</a>) is estimated to report quarterly loss at $0.43 per share on revenue of $20.58 million.
&bull; Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) is projected to report quarterly loss at $1.95 per share on revenue of $59.97 million.
&bull; NeoGames (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGMS#NASDAQ">NGMS</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $75.36 million.
&bull; Banco BBVA Argentina (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAR#NYSE">BBAR</a>) is likely to report quarterly earnings at $0.32 per share on revenue of $222.99 million.
&bull; Markforged Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKFG#NYSE">MKFG</a>) is expected to report quarterly loss at $0.07 per share on revenue of $29.35 million.
&bull; Ellington Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) is projected to report quarterly earnings at $0.22 per share on revenue of $3.92 million.
&bull; P10 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PX#NYSE">PX</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $50.90 million.
&bull; ObsEva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OBSV#NASDAQ">OBSV</a>) is projected to report earnings for its fourth quarter.
&bull; Zynex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYXI#NASDAQ">ZYXI</a>) is estimated to report quarterly earnings at $0.19 per share on revenue of $49.71 million.
&bull; Cara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) is estimated to report quarterly loss at $0.32 per share on revenue of $16.25 million.
&bull; Aris Water Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARIS#NYSE">ARIS</a>) is likely to report quarterly earnings at $0.34 per share on revenue of $128.53 million.
&bull; Commercial Vehicle Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVGI#NASDAQ">CVGI</a>) is expected to report quarterly earnings at $0.17 per share on revenue of $248.69 million.
&bull; Grindr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRND#NYSE">GRND</a>) is likely to report earnings for its fourth quarter.
&bull; WW International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WW#NASDAQ">WW</a>) is projected to report quarterly loss at $0.02 per share on revenue of $224.25 million.
&bull; Orthofix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFIX#NASDAQ">OFIX</a>) is estimated to report quarterly earnings at $0.34 per share on revenue of $121.84 million.
&bull; Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) is estimated to report quarterly loss at $0.09 per share on revenue of $214.67 million.
&bull; Gaia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAIA#NASDAQ">GAIA</a>) is projected to report quarterly loss at $0.02 per share on revenue of $20.00 million.
&bull; Pactiv Evergreen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTVE#NASDAQ">PTVE</a>) is likely to report quarterly earnings at $0.08 per share on revenue of $1.51 billion.
&bull; Tabula Rasa HealthCare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRHC#NASDAQ">TRHC</a>) is projected to report quarterly loss at $0.06 per share on revenue of $82.48 million.
&bull; Ocular Therapeutix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCUL#NASDAQ">OCUL</a>) is projected to report quarterly loss at $0.25 per share on revenue of $13.53 million.
&bull; AeroVironment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) is likely to report quarterly earnings at $1.08 per share on revenue of $169.87 million.
&bull; Domo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOMO#NASDAQ">DOMO</a>) is likely to report quarterly loss at $0.12 per share on revenue of $79.47 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.